Browse

You are looking at 301 - 350 of 871 items for :

  • Educational & Training x
  • Refine by Access: All content x
Clear All
Restricted access

Chapter 24: Heart Failure

Yazid N. Al Hamarneh and Ross T. Tsuyuki

Restricted access

Chapter 25: Ventricular Arrhythmias

James E. Tisdale

Restricted access

Chapter 26: Supraventricular Arrhythmias

James E. Tisdale

Restricted access

Chapter 27: Hypertension

Liza W. Claus and Joseph J. Saseen

Restricted access

Chapter 28: Hypotension

Katy E. Trinkley and Robert L. Page II

Restricted access

Chapter 29: Valvular and Pericardial Heart Disease

Sarah A. Spinler and Frank E. Silvestry

Restricted access

Chapter 3: Factors Contributing to Drug-Induced Diseases

Tyler Shugg, Abdullah Assiri, and Brian R. Overholser

Restricted access

Chapter 3: What Is an Opioid Use Disorder?

Wallace J. Cross

Restricted access

Chapter 30: Glucose and Insulin Dysregulation

Devra K. Dang, Frank Pucino Jr., Charles D. Ponte, and Karim Anton Calis

Restricted access

Chapter 31: Thyroid Diseases

Genevieve Lynn Ness, Judy T. Chen, Betty J. Dong, Frank Pucino Jr., and Karim Anton Calis

Restricted access

Chapter 32: Hypothalamic, Pituitary, and Adrenal Diseases

Andrew Y. Hwang, Steven M. Smith, and John G. Gums

Restricted access

Chapter 33: Sexual Dysfunction in Males

Mary Lee and Roohollah Sharifi

Restricted access

Chapter 34: Gynecologic Diseases and Infertility in Women

Judith A. Smith

Restricted access

Chapter 35: Upper Gastrointestinal Ulceration

Dianne W. May, Micaela Carroll, and J. Russell May

Restricted access

Chapter 36: Diarrhea

Sarah A. Nisly and Alison M. Walton

Restricted access

Chapter 37: Constipation

Sarah A. Nisly and Carolyn M. Jung

Restricted access

Chapter 38: Hepatic and Cholestatic Diseases

Scott S. Malinowski and Daniel M. Riche

Restricted access

Chapter 39: Pancreatitis

Pramodini B. Kale-Pradhan and Sheila M. Wilhelm

Restricted access

Chapter 4: Postmarketing Surveillance for Drug-Induced Diseases

Tobias Peschel and Hugh H. Tilson

Restricted access

Chapter 4: The Role of Pharmacists in Screening and Caring for Patients with Substance Use Disorders

Sarah T. Melton, Merrill Norton, and Michael G. O’Neil

Restricted access

Chapter 40: Nausea and Vomiting

Saeed K. Alzghari, Bonnie A. Labdi, and Jon D. Herrington

Restricted access

Chapter 41: Acute Kidney Injury

Amy Barton Pai and Nicole M. Wegrzyn

Restricted access

Chapter 42: Chronic Kidney Disease

Mary K. Stamatakis

Restricted access

Chapter 43: Syndrome of Inappropriate Antidiuretic Hormone Secretion and Diabetes Insipidus

Mark A. Malesker and Daniel E. Hilleman

Restricted access

Chapter 44: Acid–Base Disorders

Lori D. Wazny, J. Christine Davis, and Robert E. Ariano

Restricted access

Chapter 45: Bleeding Disorders

Tiffany Pon and Jaekyu Shin

Restricted access

Chapter 46: Thrombocytopenia

Kellie Jones Weddle and Patrick J. Kiel

Restricted access

Chapter 47: Thromboembolic Diseases

Candice L. Garwood

Restricted access

Chapter 48: Neutropenia and Agranulocytosis

Teresa C. Thakrar and Christopher A. Fausel

Restricted access

Chapter 49: Anemias

LeAnn B. Norris and Charles L. Bennett

Restricted access

Chapter 5: Evaluating Patients for Drug-Induced Diseases

Douglas A. Miller and James E. Tisdale

Restricted access

Chapter 5: Medications Used to Treat Opioid Overdose and Maintenance Treatment Modalities

Kathryn A. Nash and Jeffrey P. Bratberg

Restricted access

Chapter 50: Osteoporosis and Osteomalacia

Laura M. Borgelt and Danielle R. Fixen

Restricted access

Chapter 51: Gout and Hyperuricemia

Jasmine D. Gonzalvo

Restricted access

Chapter 52: Myopathy

Craig Williams

Restricted access

Chapter 53: Weight Gain

Amy Heck Sheehan

Restricted access

Chapter 54: Temperature Dysregulation

Susan M. Wilson and Ian A. Ross

Restricted access

Chapter 55: Ototoxicity

Monica L. Miller

Restricted access

Chapter 56: Oral Manifestations of Systemically Administered Drugs

Ashley H. Meredith

Restricted access

Chapter 57: Neoplastic Diseases

Sandra Cuellar and Christina Mactal Haaf

Restricted access

Chapter 58: Teratogenicity

Kylie N. Barnes

Restricted access

Chapter 6: Drug Allergy and Cutaneous Diseases

Lynne M. Sylvia

Restricted access

Chapter 6: Pain Management Considerations

Theodore V. Parran Jr.

Restricted access

Chapter 7: Detection and Deterrence of Prescription Medication Misuse and Diversion

Michael G. O’Neil and Sarah T. Melton

Restricted access

Chapter 7: Systemic Lupus Erythematosus-Like Syndrome

Karen W. Lee and Matthew F. Ambury

Restricted access

Chapter 8: Caring for the Pregnant Woman with Opioid Use Disorder and Infants with Neonatal Abstinence Syndrome

Carla Worley Saunders, Sarah T. Melton, and Michael G. O’Neil

Restricted access

Chapter 8: Photosensitivity

Julie M. Koehler

Restricted access

Chapter 9: Alopecia, Hirsutism, and Hypertrichosis

Kristine E. Keplar

Restricted access

Chapter 9: Substance Use Disorders in the Pharmacy Professional

Wallace J. Cross and Jeffrey N. Baldwin

Restricted access
Cover Drug-Induced Diseases

Drug-Induced Diseases

Prevention, Detection, and Management

Edited by James E. Tisdale and Douglas A. Miller